Despite entering its maturation phase, the recombinant protein sector will continue to drive the growth of medical biotechnology over the next six years. You have full access to this article via ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

This, along with its short life cycle and large biomass production capacity, makes it an ideal choice for quick and efficient recombinant protein production. However, despite these multiple ...

As U.S. stock markets continue to recover, with major indices closing higher for the third consecutive day, investors are cautiously optimistic about the potential easing of tariffs and its impact on ...

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.

Vaxart (NASDAQ:VXRT – Get Free Report) is expected to release its earnings data before the market opens on Thursday, March 13th. Analysts expect Vaxart to post earnings of ($0.10) per share and ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

As of now, close to 70 per cent of all recombinant proteins are produced in mammalian cells, which is crucial for the proper function of these proteins. However, protein production in mammalian cells ...

Studies suggest that by acting as a decoy receptor for myostatin—a protein believed to inhibit muscular tissue ...

Custom Recombinant Protein Production Services Market 2025 custom recombinant protein production services market is estimated to be valued ...